EcoDrugPlus

Calcium Voltage-Gated Channel Subunit Alpha1 E

Ensembl ID : ENSOSIG00000017146
Gene Symbol: CACNA1E
1 Cross references
207 Possible Orthologues:

Calcium Voltage-Gated Channel Subunit Alpha1 E

Ensembl ID : ENSOSIG00000016403
Gene Symbol: CACNA1E
1 Cross references
214 Possible Orthologues:

Calcium Voltage-Gated Channel Subunit Alpha1 H

Ensembl ID : ENSOSIG00000007062
Gene Symbol: CACNA1H
1 Cross references
208 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSOSIG00000018733
Gene Symbol: CNR1
1 Cross references
134 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSOSIG00000006132
Gene Symbol: CNR1
1 Cross references
150 Possible Orthologues:

Cannabinoid Receptor 2

Ensembl ID : ENSOSIG00000021555
Gene Symbol: CNR2
1 Cross references
191 Possible Orthologues:

Carbonic Anhydrase 12

Ensembl ID : ENSOSIG00000021346
Gene Symbol: CA12
1 Cross references
214 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSOSIG00000022835
Gene Symbol: CA6
1 Cross references
215 Possible Orthologues:

Carbonic Anhydrase Iv A

Ensembl ID : ENSOSIG00000018948
Gene Symbol: CA4A
1 Cross references
212 Possible Orthologues:

Carbonic Anhydrase Iv C

Ensembl ID : ENSOSIG00000007707
Gene Symbol: CA4C
1 Cross references
79 Possible Orthologues:

Carbonic Anhydrase Vii

Ensembl ID : ENSOSIG00000004449
Gene Symbol: CA7
1 Cross references
221 Possible Orthologues:

Carbonic Anhydrase Va

Ensembl ID : ENSOSIG00000004819
Gene Symbol: CA5A
1 Cross references
231 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).